Back to list

Suki

Voice AI medical scribe and clinical assistant for healthcare providers
Healthcare AI 📍 Redwood City, CA Founded 2017
Current Valuation
$500M
as of 2024-Q4
PRIVATE

IPO Outlookprivate

Is Suki going public?
No. Suki is private and has not filed to go public. There is no S-1 on file.
What is Suki's valuation in 2026?
Suki is valued at $500M as of 2024-Q4, set by its Series D ($70M, Oct 2024). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Suki filed an S-1?
No public S-1 is on file for Suki.
Who are Suki's investors?
Suki's investors include Hedosophia, Venrock, March Capital, Flare Capital Partners, inHealth Ventures.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Suki is a voice-enabled AI clinical assistant that helps physicians dictate notes and automate documentation directly into electronic health records. Founded in 2017 by former Google and Flipkart executive Punit Soni, Suki competes with Abridge, Microsoft's Nuance DAX, and Ambience in the rapidly consolidating ambient-AI scribe category. In October 2024, the company raised a $70M Series D led by Hedosophia at a ~$500M valuation, bringing total funding to $168M.

Company Profile

CEO
Punit Soni
Founded
2017
HQ
Redwood City, CA
Employees
~250
Total Raised
$168M
Growth
Strong ARR growth; multi-health-system deployments
Last Round
Series D — $70M (Oct 2024) · Lead: Hedosophia
IPO Status
private

Fundraising Status

Series D · $70M · 1y 10mo ago
privateTotal raised $168M

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series D$70MOct 2024Hedosophia

Vertical Intelligence — AI / ML

No verified Hugging Face organization found for Suki — no attributable open-model footprint. Closed-weights labs are common; this is a distribution signal, not a capability judgment.
Checked huggingface.co as of 2026-08-19. Re-checked weekly.

Talent Signal

Hiring trend
Hiring uptrend
57% of roles posted in last 30d
Open roles
14
via greenhouse
Product-build share
64%
engineering, research, product, design
Trajectory
expanding
product-led hiring — 64% of open roles build product; the rest are go-to-market and G&A.
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by month14Aug '26
Open roles by function
Open roles by functionEngineering4Data & ML2Product2Other2Sales & GTM1Security1Legal & Policy1Ops & People1
product-building   go-to-market / G&A
Cloud and AI Security EngineerMachine Learning Engineer III (NLP)Product Manager III (Clinical Reasoning)Senior SDET (Mobile-First Full Stack)Software ArchitectSoftware Engineer II - Backend
Counted from Suki's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.

Founders & Key People

Punit Soni

Investors

Hedosophia · Venrock · March Capital · Flare Capital Partners · inHealth Ventures

Products

  • Suki Assistant (ambient AI medical scribe)
  • Suki Platform (clinical-voice SDK for EHR partners)
  • Premier Inc. GPO-distributed AI scribe contract

Competitors

Abridge · Nuance DAX (Microsoft) · Ambience Healthcare · DeepScribe
Healthcare AIVoice AIMedical ScribeClinical DocumentationEHR
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q4. Refreshed quarterly.